- This meeting has passed.
Frontline Advancements: Clinical Data Overview of Echelon-1 and Echelon-2
May 1, 2019 @ 6:30 pm - 8:30 pm
Join Caroline Behler, MD,, on May 1 at 6:30PM to review data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphoma (PTCL).
“ANCO membership has been valuable for maintaining our involvement with legislation at the local, state and national level that can help patients and their physicians to provide “state of the art” care. ANCO is also committed to providing educational opportunities for our members with regional and national experts.”
Daniel Mirda, MD
St. Joseph Health Medical Group